Almirall appoints Peter Guenter as its CEO

Almirall has appointed Peter Guenter as its new chief executive officer, succeeding Eduardo Sanchiz who leaves to spend more time dedicated to other interests.

Guenter joins from Sanofi, where he has worked for the past 22 years, most recently as executive vice president diabetes and cardiovascular global business unit.

He said: “I am excited and eager to join Almirall as CEO. The company has a clearly defined strategy, putting the patients and customers at the centre of everything we do.

“Together with my team, I am convinced we will be able to fully unlock the value of Almirall.”

He previously held many senior positions at Sanofi, including vice president Eastern Europe and Northern Europe, vice president business management and support, general manager, Germany, and senior vice president, Europe.

Jorge Gallardo, chairman of the board, Almirall, said: “I am particularly satisfied that we have been able to attract Peter to Almirall.

“He is a truly global leader and brings a wealth of experience in US, Europe, and emerging markets. I am convinced he will bring what is needed to develop Almirall to the next level.”

Sanchiz will hand over the leadership of Almirall to Guenter during September.